Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection. [electronic resource]
Producer: 20050128Description: 769-75 p. digitalISSN:- 0944-1174
- Adult
- Aged
- Amino Acid Sequence -- genetics
- Antiviral Agents -- therapeutic use
- Chromosome Deletion
- DNA Mutational Analysis
- DNA, Viral -- blood
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Resistance, Viral -- genetics
- Female
- Hepacivirus -- drug effects
- Hepatitis B Surface Antigens -- genetics
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- therapeutic use
- Liver Function Tests
- Male
- Middle Aged
- Multivariate Analysis
- Prognosis
- Proportional Hazards Models
- Protein Precursors -- genetics
- Regression Analysis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.